24,267.94
+771.05
(+3.28%)
8,105.70
+335.44
(+4.32%)
4,760.73
+253.69
(+5.63%)
4,771.09
-21.17
(-0.442%)
14,992.56
-232.55
(-1.527%)
62,533.9900
-830.0100
(-1.310%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports